APVO
Aptevo Therapeutics Inc
NASDAQ: APVO · HEALTHCARE · BIOTECHNOLOGY
$4.81
-1.94% today
Updated 2026-04-29
Market cap
$5.68M
P/E ratio
—
P/S ratio
2.70x
EPS (TTM)
$-87.27
Dividend yield
—
52W range
$4 – $189
Volume
0.1M
Aptevo Therapeutics Inc (APVO) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $170000.00 | $45.63M | $33.60M | $36.43M | $14.66M | $23.07M | $32.42M | $4.31M | $12.29M | $3.11M | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | +26741.8% | -26.4% | +8.4% | -59.8% | +57.4% | +40.6% | -86.7% | +185.3% | -74.7% | -100.0% | — | — |
| Cost of revenue | $38.07M | $16.25M | $16.93M | $24.18M | $5.01M | $11.21M | $2.23M | $17.85M | $18.99M | $17.88M | $17.11M | $352000.00 | $240000.00 |
| Gross profit | $-37.90M | $29.38M | $16.67M | $12.25M | $9.65M | $11.85M | $-2.23M | $-13.54M | $12.29M | $3.11M | $-567000.00 | $-352000.00 | $-240000.00 |
| Gross margin | -22296.5% | 64.4% | 49.6% | 33.6% | 65.8% | 51.4% | -6.9% | -314.3% | 100.0% | 100.0% | — | — | — |
| R&D | $38.07M | $46.59M | $34.73M | $29.52M | $29.02M | $35.38M | $24.76M | $17.85M | $18.99M | $17.88M | $17.11M | $14.38M | $14.54M |
| SG&A | $15.45M | $34.28M | $43.04M | $38.67M | $34.58M | $28.13M | $16.20M | $13.95M | $14.70M | $13.87M | $11.77M | $10.22M | $11.77M |
| Operating income | $-53.35M | $-51.49M | $-61.10M | $-126.94M | $-53.95M | $-51.66M | $-40.96M | $-27.49M | $-21.40M | $-28.64M | $-28.88M | $-24.60M | $-26.31M |
| Operating margin | -31385.3% | -112.8% | -181.8% | -348.4% | -368.1% | -224.0% | -126.3% | -638.1% | -174.1% | -919.7% | — | — | — |
| EBITDA | $-52.69M | $-49.47M | $-58.19M | $-64.40M | $-48.88M | $-49.27M | $-40.83M | $-26.19M | $-20.26M | $-27.74M | $-28.31M | $-23.78M | $-26.07M |
| EBITDA margin | -30993.5% | -108.4% | -173.2% | -176.8% | -333.5% | -213.6% | -125.9% | -607.8% | -164.8% | -890.8% | — | — | — |
| EBIT | $-53.35M | $-51.49M | $-61.10M | $-66.30M | $-51.18M | $-51.66M | $-43.06M | $-27.49M | $-21.40M | $-28.64M | $-28.88M | $-24.13M | $-26.31M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $7.06M | $35.66M | — | — | — |
| Income tax | $-18000.00 | $-599000.00 | $-2.02M | $-15.34M | $-23.30M | $-23.30M | $-2.62M | $-12.47M | $-2.10M | $-35.66M | $-1.24M | — | — |
| Effective tax rate | 0.0% | 1.2% | 3.3% | 12.0% | 142.7% | 30.3% | 5.5% | 41.3% | 7.1% | 129.1% | 6.6% | 0.0% | 0.0% |
| Net income | $-53.34M | $-51.12M | $-59.32M | $-112.42M | $6.97M | $-53.69M | $-44.70M | $-17.75M | $-27.31M | $8.03M | $-17.41M | $-24.13M | $-25.97M |
| Net income growth (YoY) | — | +4.2% | -16.0% | -89.5% | +106.2% | -870.0% | +16.7% | +60.3% | -53.9% | +129.4% | -316.9% | -38.6% | -7.6% |
| Profit margin | -31374.7% | -112.0% | -176.5% | -308.5% | 47.6% | -232.8% | -137.9% | -411.9% | -222.2% | 257.8% | — | — | — |